{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:34Z","timestamp":1761129034621},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,15]]},"DOI":"10.1093\/infdis\/jis736","type":"journal-article","created":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T21:04:53Z","timestamp":1354395893000},"page":"687-688","source":"Crossref","is-referenced-by-count":16,"title":["CYP2C8 Status of Patients With Malaria Influences Selection of Plasmodium falciparum pfmdr1 Alleles After Amodiaquine-Artesunate Treatment"],"prefix":"10.1093","volume":"207","author":[{"given":"Isa","family":"Cavaco","sequence":"first","affiliation":[]},{"given":"Andreas","family":"M\u00e5rtensson","sequence":"additional","affiliation":[]},{"given":"Gabrielle","family":"Fr\u00f6berg","sequence":"additional","affiliation":[]},{"given":"Mwinyi","family":"Msellem","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 P.","family":"Gil","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"key":"key\n\t\t\t\t20170702145939_JIS736C1","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/infdis\/jir629","article-title":"Human genetic variation is associated with Plasmodium falciparum drug resistance","volume":"204","author":"Paganotti","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702145939_JIS736C2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/14622416.8.2.187","article-title":"CYP2C8 and antimalaria drug efficacy","volume":"8","author":"Gil","year":"2007","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20170702145939_JIS736C3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-003-0636-9","article-title":"Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data","volume":"59","author":"Li","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170702145939_JIS736C4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","article-title":"Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y","volume":"6","author":"Holmgren","year":"2006","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20170702145939_JIS736C5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.meegid.2007.03.005","article-title":"Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa","volume":"7","author":"Holmgren","year":"2007","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20170702145939_JIS736C6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.00875-06","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria","volume":"51","author":"Humphreys","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170702145939_JIS736C7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00228-004-0871-8","article-title":"CYP2C8 polymorphism frequencies among malaria patients in Zanzibar","volume":"61","author":"Cavaco","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170702145939_JIS736C8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/444460","article-title":"Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania","volume":"41","author":"M\u00e5rtensson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702145939_JIS736C9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.fpc.0000204995.99429.0f","article-title":"Statistical power of association using the extreme discordant phenotype design","volume":"16","author":"Zhang","year":"2006","journal-title":"Pharmacog. Genomics"},{"key":"key\n\t\t\t\t20170702145939_JIS736C10","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2217\/14622416.9.10.1385","article-title":"Amodiaquine pharmacogenetics","volume":"9","author":"Gil","year":"2008","journal-title":"Pharmacogenomics"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/207\/4\/687\/18068796\/jis736.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T10:46:39Z","timestamp":1503485199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jis736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,11,30]]},"published-print":{"date-parts":[[2013,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jis736","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,30]]}}}